ReviewInternational journal of nephrology and renovascular disease2019

Tivozanib for the treatment of renal cell carcinoma: patient selection and perspectives.

R J Rodenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.